Nemera: Company Market Research Report

Company Overview

Name

• Nemera

Mission

• To become the most patient-centric drug delivery device solutions & combination product services company.

Founded By

• No information is available

Key People

• Marc Hämel - Chief Executive Officer

• Frédéric Brunet - Chief Financial Officer

• Elizabeth De Longeaux - Vice-President Human Resources

• Denise Johnston - Vice-President Sales

• Dimitri Grasswill - Vice-President Innovation

• Bernhard Rohn - Vice-President Strategy and Marketing

• Sebastian Perrier - Chief Operating Officer

• Christian Meusinger - Vice-President Quality and Regulatory

Headquarters

• 63 avenue Tony Garnier, 69007 – Lyon, France

Number of Employees

• No information is available

Revenue

• No information is available

Known For

• Designing and manufacturing drug delivery device solutions that maximize treatment efficacy and safety for patients.

Products

Product Offerings and Features

1. Dermal Devices

• Sof’Bag®+: Airless pouch-in-bottle for dermal applications.

• Sof’Airless XS+: Protective mini-airless system for small dose applications.

• Spray Pumps: Wide range of pumps for liquid and viscous formulations.

• Child Resistant Closure: Prevents child opening while easy for adult use.

2. Ear Nose Throat (ENT) Devices

• Multidose Pump Systems: Various technologies and platforms for delivering nasal treatments.

• UniSpray: Single-metered dose delivery for emergencies.

• Nasal Vaccine Device: Under development for respiratory infections.

• Electronic Nasal Delivery Devices: Integrating electronics for enhanced nasal treatments.

3. Inhalation Devices

• DPI and pMDI: Holistic inhaler development and manufacturing for asthma and COPD.

4. Intimate Care Devices

• Vaginal and Rectal Applicators: Specialized devices for women's health and gynecological issues.

5. Ophthalmic Devices

• Novelia®: Multi-dose closing tip system that prevents bacterial contamination without preservatives.

• e-Novelia: Smart ophthalmic add-on device to improve adherence.

6. Oral Administration Devices

• Liquid Dosers and Caps: Devices for the delivery of pediatric and medical food supplements.

7. Parenteral Devices

• Safe'n'Sound®: Passive safety platform to prevent needlestick injuries.

• Pen Platforms: Comprehensive range of pen injectors for various treatments.

• Symbioze®: Wearable on-body injector to enhance patient experience.

Recent Developments

New Product Launches

• CRISPEN®: Reusable, spring-assisted pen injector commercialized in Brazil for administering human growth hormone, part of the PENDURA AD platform.

New Features and Innovations

• Leveraging expertise in nose-to-brain field for enhanced drug delivery to the CNS (Central Nervous System).

Partnerships and Collaborations

• Partnered with Cristalia for the commercialization of CRISPEN® in Brazil.

Sustainability Initiatives

• Released the 2023 ESG Report outlining Nemera's sustainability efforts and strategic priorities.

Other Notable Developments

• Continued exploration and advancements in the nasal delivery device innovations and presentations at industry conferences like DDL.

Conclusion

Nemera demonstrates a comprehensive commitment to improving drug delivery device solutions through patient-centric designs, expanding their global reach, and fostering innovation in drug delivery technologies. The company's recent developments in reusable pen injectors and their focus on sustainability and gender equality in the workplace further reinforce their reputable standing within the pharmaceutical device industry.